Piper Sandler Sticks to Its Buy Rating for Allogene Therapeutics (ALLO)
Piper Sandler analyst Biren Amin maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) today and set a price target ...
Business Insider1d
CARGO Therapeutics, Inc. (CRGX) Gets a Buy from Piper Sandler
Amin covers the Healthcare sector, focusing on stocks such as Ocular Therapeutix, Apellis Pharmaceuticals, and BridgeBio Pharma. The word on The Street in general, suggests a Strong Buy analyst ...
ETF Daily News4d
Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Lowered to $47.00 at Bank of America
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price target decreased by Bank of America from $61.00 to $47.00 ...